Clinical

Dataset Information

0

A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer


ABSTRACT: This is an open-label, Phase 2, multicenter study to evaluate the efficacy, safety, tolerability, and pharmacokinetic profiles of botensilimab as monotherapy and in combination with balstilimab or standard-of-care treatments in participants with refractory metastatic colorectal cancer.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2760681 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2298670 | ecrin-mdr-crc
| 2750736 | ecrin-mdr-crc
| 4053 | ecrin-mdr-crc
2022-06-29 | GSE157302 | GEO
| 2238528 | ecrin-mdr-crc
| phs000649 | dbGaP
2020-09-24 | GSE158403 | GEO
2017-07-07 | E-GEOD-100833 | biostudies-arrayexpress
2023-12-31 | GSE217962 | GEO
2013-07-30 | E-GEOD-37138 | biostudies-arrayexpress